Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Approval of Revised Notice of Annual General Meeting ( AGM )'.
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Akums Drugs and Pharmaceuticals has informed the stock exchanges that its Board of Directors has approved a revised Notice for the 21st Annual General Meeting (AGM) through a circular resolution dated June 7, 2025. The revision was needed because of certain developments after the original AGM Notice was approved on May 26, 2025. The only change in the revised Notice is the addition of an agenda item seeking shareholder approval for the appointment of an Independent Director. All other content of the AGM Notice remains the same.
This is a routine procedural update with no direct financial impact. Shareholders should note the new agenda item on appointing an Independent Director, which they will vote on at the upcoming AGM. It reflects active board composition decisions and compliance with corporate governance norms.